Advertisement

Topics

Accuray Inc. Company Profile

10:21 EDT 21st September 2017 | BioPortfolio


News Articles [43 Associated News Articles listed on BioPortfolio]

Accuray Inc. Release: Anova Marks 1,500th Prostate Cancer Patient Treated with the Accuray CyberKnife System

  Life Sciences Jobs   ...

Accuray to Present at Upcoming Investor Conferences

SUNNYVALE, Calif., Aug. 22, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its management is scheduled to present at two upcoming investor conferences. Accuray Incorpor...

Accuray To Report Fiscal 2017 Fourth Quarter And Full Year Results On August 22, 2017

SUNNYVALE, Calif., Aug. 14, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2017 ended June 30, 2017 on Tuesday, August 22, 2017 aft...

Accuray Incorporated's CEO to Speak at Leerink Swan Global Healthcare Conference

SUNNYVALE, Calif., Feb. 11, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its president and chief executive officer, Joshua H. Levine, is scheduled to p...

Accuray gets $52M boost in revolving loan agreement

A revolving loan agreement has been reached by Accuray with MidCap Financial Trust for a senior secured revolving loan facili -More- 

Accuray Incorporated to Speak at Needham's 15th Annual Growth Conference

SUNNYVALE, Calif., Jan. 8, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Nee...

Accuray Looks Undervalued, But A Lack Of Execution Is A Longstanding Problem

Accuray Inc. Appoints VP Of Revenue Management

cta   Life Sciences Jobs   ...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.

To evaluate efficacy and toxicity of stereotactic body radiation therapy (SBRT) with CyberKnife® (Accuray, Sunnyvale, CA, USA) in a selected cohort of primary, medically inoperable early-stage non-s...

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Accuray Incorporated

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option ...

Accuray

Accuray's history began when John R. Adler, MD, professor of neurosurgery and radiation oncology at Stanford University Medical Center, developed the CyberKnife® System in 1987 after completing a fel...

Accuray Inc.

Speck Design

Speck Design is Silicon Valley’s leading product design firm. We specialize in industrial and mechanical design services. Speck Design develops products with highly complex r...

More Information about "Accuray Inc." on BioPortfolio

We have published hundreds of Accuray Inc. news stories on BioPortfolio along with dozens of Accuray Inc. Clinical Trials and PubMed Articles about Accuray Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accuray Inc. Companies in our database. You can also find out about relevant Accuray Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record